GenScript Peptides (revision 37)

GenScript Biotech Corporation (trading as GSP; genscriptpeptides.com) is a peptide synthesis organisation trading as GenScript Peptides from Nanjing, Jiangsu, China, incorporated in 2002 and supplying research peptides, custom sequences and raw materials with batch documentation.^[1][2]

The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.^[3]

This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.^[4]

Incorporated in Nanjing in 2002, the organisation sits with the earlier incorporation dates among the entities covered on this wiki and predates the current research-peptide market by roughly a decade.^[1] Nanjing is inside the Yangtze River Delta manufacturing belt, and the organisation's own material describes a business built on solid-phase synthesis and custom sequence work rather than on catalogue distribution alone.^[2]

The organisation describes itself as performing its own synthesis rather than finishing material made elsewhere. That is a self-published characterisation and is recorded here as one: nothing available to this wiki establishes the manufacturing arrangements behind it, and a registered business scope is a licensing fact rather than a capability finding.^[2][1] What can be said from the submitted material is narrower and more useful — purchasers report that questions about a synthesis route, a coupling or a purification step are answered with specifics rather than referred onward, which is consistent with the claim without establishing it.^[5]

The documentary base is the registry record, the organisation's own material and purchaser-submitted test reports. No independent coverage has been identified, which is a characteristic of the sector rather than of this entity.

The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.

Purchaser reports describe vialled lyophilised material arriving with a batch-specific certificate naming a lot, and across the submitted set the lot string on the certificate has corresponded to the vial label.^[5] That correspondence is a minimum requirement rather than an achievement, and it is recorded only because traceability fails often enough elsewhere in this sector to make its absence the more common finding.

Water content by Karl Fischer titration appears on the certificates described in the submitted set, and peptide content is reported on a separate line from chromatographic purity across a substantial part of it.^[5][6] Those two determinations are what let a purity percentage be read as a statement about mass, and their routine presence is the most useful documentary observation available about this organisation. The column, the gradient and the detection wavelength are described as printed on the document rather than supplied on request, which makes the separation reproducible in principle by a reader with access to the instrument.^[5]

One operational observation recurs often enough in the submitted set to belong in the article, and it is not about material. Purchasers describe a delay of four to five working days in obtaining a written quotation for a custom sequence, against same-day acknowledgement on catalogue enquiries; work performed against an accepted quotation is described as meeting its stated date.^[5] The distinction matters to a reader planning a schedule and is recorded for that reason rather than as a criticism of the material.

What the record does not establish is the physical arrangement of manufacture, whether any given line is synthesised in-house or contracted out, or what quality system governs it. Statements to that effect in the organisation's own material are self-published and are not corroborated here.^[2][7]

The custom-synthesis listings are documented differently from the catalogue lines — a certificate stating the analytical conditions under which the material was released, rather than a single purity figure against a catalogue specification. Purchaser reports describe the quotation as carrying a purity target and a timeline before the order is accepted.^[5] Whether the synthesis is performed at the Nanjing site named in the organisation's own material is not established by any source available to this wiki, and a reader should treat the attribution as a claim until it is.^[2]

Reports on GSP material submitted to PeptidePedia between 2024 and 2026 cover the incretin analogues most heavily, with a smaller set on repair and secretagogue peptides and a handful on bulk raw material. Reported area percent figures have been high across the set, and where a report and the accompanying certificate can be compared the two have generally agreed within a few tenths of a percentage point, with the certificate figure the lower of the two in the comparisons on file.^[5]

The submitted set covers a small number of the listed compounds. A reader should not read agreement on eight lines as a finding about three hundred and fifty; the unsubmitted lines are unmeasured rather than sound, and this wiki has no mechanism for establishing anything about them.^[5]

Catalogue lines dispatch from held stock, and the organisation's own material states a same-day or next-working-day dispatch window on listed items.^[2] Bulk raw-material quantities and custom synthesis are quoted individually, with a timeline stated on the quotation; submissions describe delivery at or inside that date.^[5] Submissions also describe the quotation itself taking four to five working days to arrive on custom work, which is the interval a reader planning a schedule should budget for, since it precedes the stated timeline rather than being contained by it.^[5]

The one check that needs no equipment is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See Lot traceability. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page.

Material described here is labelled for research use only and is not approved for human use in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them.

Go to the GSP catalogue →

The PeptidePedia tally records 870 self-reported submissions concerning GSP to July 2026. What recurs across them is certificate completeness — water and content determinations described as present on the document as issued rather than supplied on request — together with agreement between a reorder and the original order of the same line.^[4] A second theme recurs and is recorded because omitting it would curate the entry: a delay of four to five working days in obtaining a written quotation for a custom sequence, against same-day acknowledgement on catalogue enquiries.^[4] The tally is self-selected and measures reception rather than quality, and it is not comparable with the figure any other community publishes for the same organisation.^[4]

The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is weak evidence and is subject to three limitations that apply to every such figure on this wiki:

• Self-selection. People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions.
• It measures reception, not quality. Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly.
• It is not comparable across communities. Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.^[4]

PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.^[4]

The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.^[1]

Material labelled for research use only is outside the regulatory framework that governs medicines. Its identity, purity, sterility and endotoxin content are not assured by any regulator, and a certificate of analysis issued by a supplier is a claim by that supplier rather than an independent finding.^[3][6]

Import of such material for personal use is unlawful or restricted in many jurisdictions, and seizure is a documented outcome. PeptidePedia describes the legal position and does not advise on it.^[3]

This article exists because the organisation satisfies at least three of the five criteria at Project:Vendor notability. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.^[1][2][5]

What is not available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.^[2]

Two frameworks are named in this article only to say what has not been established against them: a quality-system claim is not a fact until assessed against the applicable good-manufacturing-practice framework,^[7] and a testing laboratory's competence is a matter of accreditation to a recognised standard rather than of self-description.^[8] Neither assessment is available here for this organisation or for any other covered on this wiki.

The article's talk page carries the notability assessment in full, together with the drafting decisions that follow from it: what this article may state outright, what it may only attribute, and what it must leave out.

• GenScript Biotech Corporation — official site (genscriptpeptides.com) — the organisation's own catalogue, stock listing and ordering pages. Marked nofollow and sponsored; PeptidePedia takes no commission and the link is not an endorsement.
• Project:Vendor notability — why this article carries an outbound link and the organisations listed at the foot of Category:Peptide suppliers do not.

• Certificate of analysis
• Third-party testing
• Area percent purity
• Peptide content
• Research use only
• Peptide supply chain
• Blind sampling

• Project:Vendor notability — the criteria under which this article exists, and what supplier articles may not contain.
• Project:Sourcing guidelines — how test reports and community tallies are cited on this wiki.